» Articles » PMID: 24885510

Diagnostic Sensitivity of Carbohydrate Deficient Transferrin in Heavy Drinkers

Abstract

Background And Aim: Carbohydrate deficient transferrin (CDT) is the most specific serum biomarker of heavy alcohol consumption, defined as ≥ 350-420 g alcohol/week. Despite introduction of a standardized reference measurement technique, widespread use of CDT remains limited due to low sensitivity. The aim of this study was to determine the factors that affect diagnostic sensitivity in patients with sustained heavy alcohol intake.

Methods: Patients with a self-reported history of sustained heavy alcohol consumption were recruited from the hepatology outpatient department or medical wards. Each patient was interviewed with a validated structured questionnaire of alcohol consumption and CDT analysis using the standardized reference measurement technique with high performance liquid chromatography was performed on serum collected at time of interview.

Results: 52 patients were recruited: 19 from the hepatology outpatient department and 33 from general medical wards. Median alcohol intake was 1013 (range 366-5880) g/week over the preceding two week period. 26 patients had a diagnostic CDT based on a threshold value of %CDT > 1.7 indicating heavy alcohol consumption, yielding a sensitivity of 50%. Overweight/obesity (defined as body mass index (BMI) ≥ 25 kg/m2 in Caucasians and ≥ 23.0 kg/m2 in Asians), female gender and presence of cirrhosis were independently associated with non-diagnostic %CDT (≤ 1.7).

Conclusions: CDT has limited sensitivity as a biomarker of heavy alcohol consumption. Caution should be applied when ordering and interpreting %CDT results, particularly in women, patients with cirrhosis and those with an elevated BMI.

Citing Articles

Development and Validation of a Fast and Sensitive UPLC-MS/MS Method for Ethyl Glucuronide (EtG) in Hair, Application to Real Cases and Comparison with Carbohydrate-Deficient Transferrin (CDT) in Serum.

Romani L, Mannocchi G, Mineo F, Vernich F, Stefani L, Marsella L Int J Mol Sci. 2025; 26(3).

PMID: 39941113 PMC: 11818164. DOI: 10.3390/ijms26031344.


Blunted reward-related activation to food scenes distinguishes individuals with alcohol use disorder in a pilot case-control fMRI pilot study.

Mellick W, McTeague L, Hix S, Anton R, Prisciandaro J Alcohol Clin Exp Res (Hoboken). 2024; 48(10):1866-1875.

PMID: 39312084 PMC: 11492229. DOI: 10.1111/acer.15419.


Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder.

Haque L, Leggio L Hepatology. 2024; 80(6):1408-1423.

PMID: 38935926 PMC: 11841743. DOI: 10.1097/HEP.0000000000000996.


ACG Clinical Guideline: Alcohol-Associated Liver Disease.

Jophlin L, Singal A, Bataller R, Wong R, Sauer B, Terrault N Am J Gastroenterol. 2024; 119(1):30-54.

PMID: 38174913 PMC: 11040545. DOI: 10.14309/ajg.0000000000002572.


Blood Biomarkers of Alcohol Use: A Scoping Review.

Harris J, Leggio L, Farokhnia M Curr Addict Rep. 2023; 8(4):500-508.

PMID: 37274945 PMC: 10237590. DOI: 10.1007/s40429-021-00402-7.


References
1.
Whitfield J, Fletcher L, MURPHY T, Powell L, Halliday J, Heath A . Smoking, obesity, and hypertension alter the dose-response curve and test sensitivity of carbohydrate-deficient transferrin as a marker of alcohol intake. Clin Chem. 1998; 44(12):2480-9. View

2.
Tsochatzis E, Gurusamy K, Ntaoula S, Cholongitas E, Davidson B, Burroughs A . Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol. 2010; 54(4):650-9. DOI: 10.1016/j.jhep.2010.07.033. View

3.
Ridinger M, Kohl P, Gabele E, Wodarz N, Schmitz G, Kiefer P . Analysis of carbohydrate deficient transferrin serum levels during abstinence. Exp Mol Pathol. 2011; 92(1):50-3. DOI: 10.1016/j.yexmp.2011.10.005. View

4.
Van Campenhout A, Van Campenhout C, Olyslager Y, Van Damme O, Lagrou A, Manuel-y-Keenoy B . A novel method to quantify in vivo transferrin glycation: applications in diabetes mellitus. Clin Chim Acta. 2006; 370(1-2):115-23. DOI: 10.1016/j.cca.2006.01.028. View

5.
Helander A, Wielders J, Jeppsson J, Weykamp C, Siebelder C, Anton R . Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: II. Performance of a laboratory network running the HPLC candidate reference measurement procedure and evaluation of a candidate reference material. Clin Chem Lab Med. 2010; 48(11):1585-92. DOI: 10.1515/CCLM.2010.322. View